Abstract Number: 325 • 2019 ACR/ARP Annual Meeting
Frailty and Sarcopenia in Inflammatory Rheumatic Disease
Background/Purpose: Sarcopenia, the loss of skeletal muscle mass, is associated with adverse individual physical and metabolic changes contributing to morbidity and mortality. Sarcopenia is a…Abstract Number: 326 • 2019 ACR/ARP Annual Meeting
Cardiac Sarcoidosis Awareness: Are We Underdiagnosing?
Background/Purpose: Sarcoidosis, a multiorgan granulomatous disorder, may involve the heart at any time and often presents with cardiac conduction disturbances, heart failure, and sudden death.…Abstract Number: 327 • 2019 ACR/ARP Annual Meeting
Presentation Order Bias in Rheumatology Journals: A Content Analysis
Background/Purpose: Presentation order can influence the prominence of an academic article. Earlier-listed items or those at the top of tables of contents are more likely…Abstract Number: 328 • 2019 ACR/ARP Annual Meeting
Adverse Events During Colchicine Use: A Systematic Review and Meta-Analysis of Randomized Controlled Trial Events
Background/Purpose: Colchicine is a widely used drug used to treat rheumatic and inflammatory conditions. Due to its long historical use in medicine, controlled clinical trials…Abstract Number: 329 • 2019 ACR/ARP Annual Meeting
Excessive Alcohol Intake Is Associated with Tophi Formation in Gout Patients
Background/Purpose: Dietary factors have been recognized as risk factors of hyperuricemia and gout. However, their association with tophi formation remain elusive. The aim of this…Abstract Number: 330 • 2019 ACR/ARP Annual Meeting
Acute Gout Attacks Among Patients Admitted Due to Heart Failure: Analysis of NIS Database
Background/Purpose: Acute gout arthropathy is a well-described side effect of aggressive diuresis in patients hospitalized with heart failure. This study aims to determine the prevalence…Abstract Number: 331 • 2019 ACR/ARP Annual Meeting
Gout Management in the Medical Community: A Claims-Based Analysis
Background/Purpose: Gout is one of the most common inflammatory arthropathies. Despite available urate lowering therapies (ULT), many patients progress to chronic or advanced gout, characterized…Abstract Number: 332 • 2019 ACR/ARP Annual Meeting
Incident Gout After Renal Transplantation in Gout-naïve Patients: Large Database Analysis
Background/Purpose: Patients undergoing kidney transplantation are at increased risk for developing hyperuricemia and gout compared to the general population (generally attributed to the frequent use…Abstract Number: 333 • 2019 ACR/ARP Annual Meeting
Assessing the Relationship Between Gout and Return to Hemodialysis Among U.S. Renal Transplant Patients
Background/Purpose: Although gout has been shown to be associated with poor renal outcomes among chronic kidney disease populations, this relationship is not well understood among…Abstract Number: 334 • 2019 ACR/ARP Annual Meeting
The Role of a ‘Treat-to-Target’ Approach on Long-term Renal Outcomes in Patients with Gout
Background/Purpose: Although gout is accompanied by the substantial burden of kidney disease, there is limited data to assess renal function as a therapeutic target. There…Abstract Number: 335 • 2019 ACR/ARP Annual Meeting
Renal Transplant Complications in Patients with and Without Gout
Background/Purpose: Graft-related complications are among the most serious issues solid-organ transplant recipients and their healthcare teams face post-operatively. Gout is a known frequent co-morbidity in…Abstract Number: 336 • 2019 ACR/ARP Annual Meeting
Treating Gout to Target Entails Renoprotective Effect in Patients with Moderate Chronic Kidney Disease
Background/Purpose: Approximately 25% of patients with gouty arthritis suffer from chronic kidney disease (CKD). High serum uric acid (sUA) levels have been related to glomerular…Abstract Number: 337 • 2019 ACR/ARP Annual Meeting
Gout in the US: Significant Association with Cardiovascular and Renal Disease Hospitalizations – A Nationwide Study
Background/Purpose: Gout is a disorder of uric acid metabolism and often presents as acute severe joint pain. Previous work from our group suggests that all-cause…Abstract Number: 338 • 2019 ACR/ARP Annual Meeting
Effect of Serum Urate Lowering with Allopurinol on Blood Pressure in Young Adults
Background/Purpose: The association between serum urate and hypertension continues to be a matter of controversy. Studies in adolescents provided evidence for the efficacy of urate…Abstract Number: 339 • 2019 ACR/ARP Annual Meeting
Depressive Symptoms Influence Success of Allopurinol in Reducing Serum Urate
Background/Purpose: Elevated levels of serum urate (sUA) are central to the pathogenesis of gout and have been associated with cardiovascular disease. Urate-lowering therapies are effective…
- « Previous Page
- 1
- …
- 974
- 975
- 976
- 977
- 978
- …
- 2425
- Next Page »